期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

人类免疫缺陷病毒感染老年患者综合诊治的特点 被引量：2

原文传递
导出
摘要 随着高效抗反转录病毒治疗（HAART）的出现,人类免疫缺陷病毒（HIV）的老年感染者（年龄≥50岁）显著增加。这不仅仅是因为许多年轻时感染的患者如今已经活至50岁以上,而且也是因为患者感染时的平均年龄已增加。
作者 郑毓芳 卢洪洲
机构地区 上海市公共卫生临床中心感染一科 复旦大学附属华山医院感染病科
出处 《内科理论与实践》 2013年第2期84-88,共5页 Journal of Internal Medicine Concepts & Practice
关键词 人类免疫缺陷病毒 老年人 抗反转录病毒药物
分类号 R512.91 [医药卫生—内科学]
  • 相关文献

参考文献45

  • 1Althoff KN, Gebo KA, Gange SJ, et al. CD4 count at pre-sentation for HIV care in the United States and Canada:are those over 50 years more likely to have a delayedpresentation? [J]. AIDS Res Ther, 2010,7: 45.
  • 2Centers for Disease Control and Prevention. HIV/AIDSsurveillance in Europe 2008 [EB/OL]. http://ec.europa.eu/health/sti_prevention/docs/ecdc_hiv_aids_surveillance_in_europe_en.pdf.
  • 3Effros RB, Fletcher CV, Gebo K, et al. Aging and infec-tious diseases: workshop on HIV infection and aging:what is known and future research directions [J]. ClinInfect Dis, 2008, 47(4): 542-553.
  • 4Bakanda C, Birungi J, Mwesigwa R, et al. Association ofaging and survival in a large HIV-infected cohort on an-tiretroviral therapy [J]. AIDS, 2011, 25(5): 701-705.
  • 5Hasse B, Ledergerber B, Egger M, et al. Aging and (non-HlV-associated) co-morbidity in HIV-positive persons:the Swiss HIV cohort study (SHCS) [EB/OL]. http://www.natap.org/2011/CR0I/agingswisscohort792.pdf.
  • 6Touloumi G, Pantazis N, Babiker AG, et al. Differencesin HIV RNA levels before the initiation of antiretroviraltherapy among 1864 individuals with known HIV-1 sero-conversion dates [J]. AIDS,2004,18(12): 1697-1705.
  • 7CASCADE Collaboration. Differences in CD4 cell countsat seroconversion and decline among 5739 HIV-1-infect-ed individuals with well-estimated dates of seroconver-sion [J]. J Acquir Immune Defic Syndr, 2003,34(1): 76-83.
  • 8Collaborative Group on AIDS Incubation and HIV Sur-vival including the CASCADE EU Concerted Action.
  • 9om HIV-1 seroconversion to AIDS and deathbefore widespread use of highly-active antiretroviraltherapy: a collaborative re-analysis [J]. Lancet, 2000,355(9210): 1131-1137.
  • 10Sabin CA, Smith CJ, d’Arminio Monforte A, et al. Re-sponse to combination antiretroviral therapy: variation byage [J]. AIDS, 2008,22(12): 1463-1473.

同被引文献20

  • 1黄高贵,李松,陈庆玲,张俊,蒋忠亮,郭跃,黄峇缅.红河州HIV/A IDS人群心理健康状况调查[J].中国健康心理学杂志,2004,12(6):464-465. 被引量：21
  • 2Jin Y,Liu Z,Wang X,et al.A systematic review of cohort studies of the quality of life in HIV/AIDS patients after antiretroviral therapy. International Journal of STD&AIDS,2014,25(11):771-777.
  • 3Martin F,Russell S,Seeley J.Higher Quality of Life and Lower Depression for People on ART in Uganda as Compared to a Community Control Group.PloS One,2014,9(8):e 105154.
  • 4Munene E,Ekman B.Does duration on antiretroviral therapy determine health-related quality of life in people living with HIV?A cross-sectional study in a regional referral hospital in Kenya.Global Health Action,2014,7:23554.
  • 5Vigneshwaran E,Padmanabhareddy Y,Devanna N,et al.Gender Differences in Health Related Quality of Life of People Living with HIV/AIDS in the Era of Highly Active Antiretroviral Therapy. North American Journal of Medical Sciences,2013,5(2):102-107.
  • 6Jaquet A,Garanet F,Balestre E,et al.Antiretroviral treatment and quality of life in Africans living with HIV:12-month follow- up in Burkina Faso.Journal of the International AIDS Society, 2013,16:18867.
  • 7Stangl A L,Wamai N,Mermin J,et al.Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda.AIDS Care-Psychological and Socio-Medical Aspects of AIDS/HIV,2007,19(5):626-636.
  • 8刘为民,何丽云,王建,刘保延,Mark van OMMEREN,方积乾,刘颖.世界卫生组织艾滋病生存质量量表中文版介绍及其使用说明[J].中国中医药信息杂志,2009,16(10):1-2. 被引量：62
  • 9刘志斌,金艳涛,刘会娟,郭会军,蒋自强.服用ARV药物致低血红蛋白血症艾滋病患者生存质量及其影响因素分析[J].中国皮肤性病学杂志,2012,26(3):226-228. 被引量：14
  • 10曾琳,马建萍,艾合买提江,马秀兰,张颖,李静茹.平艾合剂1号方改善AIDS/HIV感染者生存质量的研究[J].新中医,2012,44(8):60-61. 被引量：12

引证文献2

二级引证文献20

内科理论与实践
2013年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部